FDA to Examine Possible Apple Watch Role in Drug Development

July 17, 2019, 11:01 AM

That device strapped to your wrist might help advance science. The Food and Drug Administration is studying whether information generated by Apple Watch users can be useful for making regulatory decisions about drugs.

Testing Reliability: The FDA is funding a study on the reliability of watch data by Yale University and the Mayo Clinic, in which people wear both the watch and a medical device that also captures things like heart rate and blood oxygen levels.

Real-Time Data: The research could mark a turning point in leveraging mobile technology to capture patient data around the clock and in real time, ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.